Inspired by a real patient.

How does it work?1,2

ELIGARD® is an androgen deprivation therapy (ADT) that helps lower testosterone levels, which may slow the growth of prostate cancer.

Personalized dosing1

You and your doctor have 4 dosing options to choose from.

Educational resources

Comprehensive resources are available to you as you navigate your journey with prostate cancer.

Man and a woman standing next to a nurse with a clipboard

Patient considerations

Your ADT should fit into your lifestyle—consider things like:
  • personalized dosing
  • route of administration
  • other medications you might be taking
  • financial support
  • additional resources

Did you know?

3.3M

Men in the US are still alive today after receiving a prostate cancer diagnosis3

67

Is the average age of diagnosis3

70%

The increased risk of African American men developing prostate cancer compared to non-Hispanic white men4

1 in 8

Men in the US will be diagnosed with prostate cancer in their lifetime, making it the most diagnosed cancer in men in 20244
References: 1. ELIGARD (leuprolide acetate). Prescribing Information. Tolmar, Inc. 2024. 2. NCCN Guidelines for Patients®: Advanced-Stage Prostate Cancer. National Comprehensive Cancer Network; 2024. 3. Key statistics for prostate cancer. American Cancer Society. Updated January 19, 2024. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html 4. Cancer Facts & Figures 2024. American Cancer Society; 2024.

Other links

You are now leaving ELIGARD.com.

Are you sure you want to leave? 

You are now navigating to the healthcare provider site.

Are you a healthcare provider?

Skip to content